Skip to the content

Congratulations to the 2026 Finalists and Winners

The 2026 CDMO Leadership Awards finalists and winners were selected based on direct feedback from biopharma decision makers and independently analyzed by our research partner, Tufts Center for the Study of Drug Development.

Winners are featured at the top of each category, followed by the additional finalists.

CDMOs are grouped into two revenue-based categories, Large and Small/Mid-Sized, so companies are evaluated among similar peers. For the purposes of the awards, $1B in CDMO revenue is used as the threshold between the two groups.

CDMO of the Year

Biologic CDMO of the Year

Large CDMOs

Winner
WuXi Biologics
Finalists
  • AbbVie
  • Samsung Biologics

Small/Mid-Sized CDMOs

Winner
Eurofins
Finalists
  • KBI Biopharma
  • Pharmaron

Cell & Gene Therapy CDMO of the Year

Large CDMOs

Winner
MilliporeSigma
Finalists
  • Lonza
  • Recipharm

Small/Mid-Sized CDMOs

Winner
Aldevron
Finalists
  • Ajinomoto Bio-Pharma Services

Small Molecule API CDMO of the Year

Large CDMOs

Winner
Lonza
Finalists
  • Almac
  • WuXi STA

Small/Mid-Sized CDMOs

Winner
Asymchem
Finalists
  • Esteve CDMO
  • Pharmaron

Small Molecule Finished Dose CDMO of the Year

Sponsored by MasterControl

Large CDMOs

Winner
Vetter Pharma
Finalists
  • Lonza
  • WuXi STA

Small/Mid-Sized CDMOs

Winner
Bend Bioscience
Finalists
  • Corden Pharma
  • Pharmaron

Fill-Finish CDMO of the Year

Large CDMOs

Winner
AbbVie
Finalists
  • Vetter Pharma
  • WuXi Biologics

Small/Mid-Sized CDMOs

Winner
KBI Biopharma
Finalists
  • Eurofins
  • Syngene International

Best in Class

The companies below represent the top performers in each Best in Class attribute by modality and company size.

Large Biologic

Analytical Services
Winner
WuXi Biologics
Finalists
  • MilliporeSigma
  • Lonza
Overall Staff
Winner
WuXi Biologics
Finalists
  • AbbVie
  • Samsung Biologics
Project Management
Winner
WuXi Biologics
Finalists
  • Samsung Biologics
  • AbbVie
Cultural Fit
Winner
Samsung Biologics
Finalists
  • AbbVie
  • WuXi Biologics
Technology Use
Winner
MilliporeSigma
Finalists
  • WuXi Biologics
  • AbbVie
Scaling Support
Winner
WuXi Biologics
Finalists
  • AbbVie
  • Samsung Biologics

Large Cell & Gene Therapy

Analytical Services
Winner
MilliporeSigma
Finalists
  • Recipharm
  • FUJIFILM Biotechnologies
Overall Staff
Winner
MilliporeSigma
Finalists
  • Recipharm
  • Thermo Fisher Scientific
Project Management
Winner
MilliporeSigma
Finalists
  • Recipharm
  • Lonza
Cultural Fit
Winner
MilliporeSigma
Finalists
  • Lonza
  • Recipharm
Technology Use
Winner
MilliporeSigma
Finalists
  • Recipharm
  • Lonza
Scaling Support
Winner
Recipharm
Finalists
  • Thermo Fisher Scientific
  • MilliporeSigma

Large Small Molecule API

Analytical Services
Winner
Lonza
Finalists
  • MilliporeSigma
  • WuXi STA
Overall Staff
Winner
Lonza
Finalists
  • MilliporeSigma
  • Curia
Project Management
Winner
Lonza
Finalists
  • Curia
  • Almac
Cultural Fit
Winner
Lonza
Finalists
  • Almac
  • MilliporeSigma
Technology Use
Winner
MilliporeSigma
Finalists
  • Lonza
  • Almac
Scaling Support
Winner
Curia
Finalists
  • WuXi STA
  • Almac

Large Small Molecule Finished Dose

Analytical Services
Winner
Vetter Pharma
Finalists
  • WuXi STA
  • Lonza
Overall Staff
Winner
Vetter Pharma
Finalists
  • Lonza
  • Catalent
Project Management
Winner
Vetter Pharma
Finalists
  • Lonza
  • Catalent
Cultural Fit
Winner
Lonza
Finalists
  • Vetter Pharma
  • Catalent
Technology Use
Winner
Vetter Pharma
Finalists
  • Lonza
  • Thermo Fisher Scientific
Scaling Support
Winner
WuXi STA
Finalists
  • Catalent
  • Thermo Fisher Scientific

Small/Mid-Sized Biologic

Analytical Services
Winner
Simtra BioPharma Solutions
Finalists
  • Pharmaron
  • KBI Biopharma
Overall Staff
Winner
Simtra BioPharma Solutions
Finalists
  • KBI Biopharma
  • IDT Biologika
Project Management
Winner
Simtra BioPharma Solutions
Finalists
  • Abzena
  • KBI Biopharma
Cultural Fit
Winner
KBI Biopharma
Finalists
  • AGC Biologics
  • Eurofins
Technology Use
Winner
Simtra BioPharma Solutions
Finalists
  • KBI Biopharma
  • Abzena
Scaling Support
Winner
Simtra BioPharma Solutions
Finalists
  • AGC Biologics
  • PCI Pharma Services

Small/Mid-Sized Cell & Gene Therapy

Analytical Services
Winner
Aldevron
Finalists
  • AGC Biologics
  • IDT Biologika
Overall Staff
Winner
Aldevron
Finalists
  • IDT Biologika
  • Ajinomoto Bio-Pharma Services
Project Management
Winner
Aldevron
Finalists
  • IDT Biologika
  • Ajinomoto Bio-Pharma Services
Cultural Fit
Winner
Aldevron
Finalists
  • IDT Biologika
  • Ajinomoto Bio-Pharma Services
Technology Use
Winner
Aldevron
Finalists
  • IDT Biologika
  • Cellipont
Scaling Support
Winner
Aldevron
Finalists
  • IDT Biologika
  • Ajinomoto Bio-Pharma Services

Small/Mid-Sized Small Molecule API

Analytical Services
Winner
Alcami
Finalists
  • AGC Pharma Chemicals
  • Pharmaron
Overall Staff
Winner
AGC Pharma Chemicals
Finalists
  • Veranova
  • Asymchem
Project Management
Winner
Veranova
Finalists
  • AGC Pharma Chemicals
  • AGC Pharma Chemicals
Cultural Fit
Winner
AGC Pharma Chemicals
Finalists
  • Veranova
  • Esteve
Technology Use
Winner
AGC Pharma Chemicals
Finalists
  • Esteve
  • Asymchem
Scaling Support
Winner
AGC Pharma Chemicals
Finalists
  • Asymchem
  • Veranova

Small/Mid-Sized Small Molecule Finished Dose

Analytical Services
Winner
Asymchem
Finalists
  • Bend Bioscience
  • Alcami
Overall Staff
Winner
Grifols International S.A.
Finalists
  • Asymchem
  • Corden Pharma
Project Management
Winner
Grifols International S.A.
Finalists
  • Corden Pharma
  • Asymchem
Cultural Fit
Winner
Grifols International S.A.
Finalists
  • Corden Pharma
  • Asymchem
Technology Use
Winner
Corden Pharma
Finalists
  • Asymchem
  • Pharmaron
Scaling Support
Winner
Grifols International S.A.
Finalists
  • Asymchem
  • Corden Pharma

Jury Awards

Most Innovative CDMO

Sponsored by CAI

Recognizes a CDMO that has demonstrated meaningful innovation with real-world impact, whether through advanced development approaches, novel delivery technologies, application of AI, or manufacturing excellence that improves outcomes for partners.

Small Molecule

Winner
Esteve CDMO
Finalists
  • Carbogen Amcis
  • Upperton Pharma Solutions
  • Veranova

Biologics

Winner
FUJIFILM Biotechnologies
Finalists
  • AGC Biologics
  • Just-Evotec Biologics
  • Rentschler Biopharma

Cell & Gene Therapy

Winner
Oxford BioMedica
Finalists
  • NorthX Biologics
  • ProBioGen
  • Viralgen

Best New or Relaunched CDMO

Honors a CDMO that has successfully entered the market or reintroduced itself through a significant relaunch, showing clear strategic focus, differentiation, and early momentum with biopharma partners.

Winner
Lotte Biologics
Finalists
  • Ardena
  • Axplora
  • Biovectra
  • Minaris Advanced Therapies
  • Rezon Bio
  • Simtra BioPharma Solutions

Best CDMO Management Team

Recognizes an executive leadership team that has demonstrated strong vision, execution, and culture, driving sustained growth, operational excellence, and trusted client partnerships.

Winner
Siegfried
Finalists
  • 3PBiovian
  • Dottikon
  • Grand River Aseptic Manufacturing
  • IDT Biologika

Best Private Equity Team Supporting the CDMO Industry

Honors a private equity team that has played a meaningful role in strengthening the CDMO sector through thoughtful investment, long-term strategy, and support of operational and organizational excellence.

Winner
GHO Capital
Finalists
  • 1315 Capital
  • EQT
  • Permira
  • Thomas H. Lee Partners
  • Warburg Pincus

Sustainability Leadership Award

Sponsored by Federal Equipment Company

Recognizes a CDMO that has demonstrated measurable progress in advancing sustainable manufacturing practices, reducing environmental impact while strengthening operational efficiency and long-term industry resilience.

Winner
Samsung Biologics
Finalists
  • Boehringer Ingelheim BioXcellence
  • Lonza
  • Thermo Fisher Scientific
  • Vetter Pharma

Lifetime Achievement Award

2026 Honoree

Derrick Hennicke

Derrick Hennicke is the recipient of the 2026 Lifetime Achievement Award, recognized for a career that has helped shape the modern CDMO industry through entrepreneurial leadership, operational discipline, and a clear commitment to advancing outsourcing as a strategic model. Over more than three decades, he has built and led organizations, guided growth across evolving modalities, and supported the development of capabilities that better serve the needs of drug developers. Beyond the companies he has helped establish and scale, his influence extends across the broader ecosystem through mentorship, advisory roles, and a consistent focus on strengthening partnerships between sponsors and service providers. His contributions have had a lasting impact on how the industry operates today and how it continues to evolve.

2026 CDMO Leadership Award Sponsors